Mechanochemistry towards greener pharmaceuticals

Innovative processes to revolutionise how we manufacture drugs and chemicals

Greener pharma

The pharmaceutical industry generates tons of toxic waste and carbon emissions. Moreover, it often relies on the supply chains of chemicals and catalysts, which limits timely production during emergencies.

Read More


Mechanochemistry gets rid of solvents. It uses mechanical force, like grinding and milling, to drive chemical reactions. It’s succesfully used by other industrial sectors (aerospace, cosmetics, fertilisers…). Now, IMPACTIVE will validate its use in pharma.

Read More

An impactful solution

IMPACTIVE is a project funded by the European Commission, which counts on 17 partners in 10 different countries. Our expertise covers the whole value chain, from research to industry and innovation, which will ensure our solutions find ways to market.

Read More

Strong industrial collaboration

IMPACTIVE counts with the industry from the start. 2 international companies (Merck & Novartis) are part of the project, to help with the scaling up.

Mashing molecules: an innovative solution towards greener pharmaceuticals

IMPACTIVE is a project funded by Horizon Europe to study the possibilities of mechanochemistry in the synthesis of active pharmaceutical ingredients. This initiative counts on 17 partners in academia and industry, which will work together towards green production processes to increase sustainability and reinforce the European supply chain.

Read more

IMPACTIVE holds kick-off meeting in Montpellier

IMPACTIVE held its official kick-off meeting in Montpellier. The project will make mechanochemistry an industrial reality, to reduce the carbon emissions of the pharmaceutical industry.

Read more

Our website is live!

IMPACTIVE launches its brand-new website, an online hub to find all the updates about our project, results, and activities

Read more